Migraine and Cluster Headaches News

Migraines to cluster headaches: The most painful headaches you could ever have - CNN



CNN
 
Migraines to cluster headaches: The most painful headaches you could ever have 
CNN
There's no cure for a cluster headache, and treatment is more complicated than a simple pill. In many cases, treatment involves breathing pure oxygen; injecting sumatriptan, a drug used to treat migraines; or inhaling a nasal form of local anesthetic ...

and more » 


The most painful headaches you could ever have - Channel3000.com - WISC-TV3



Channel3000.com - WISC-TV3
 
The most painful headaches you could ever have 
Channel3000.com - WISC-TV3
There's no cure for a cluster headache, and treatment is more complicated than a simple pill. In many cases, treatment involves breathing pure oxygen; injecting sumatriptan, a drug used to treat migraines; or inhaling a nasal form of local anesthetic ...

and more » 


Treating Cluster Headache: Weighing Current Therapies - Neurology Advisor



Neurology Advisor
 
Treating Cluster Headache: Weighing Current Therapies 
Neurology Advisor
Of the various identified types of headache, cluster headache (CH) is considered the most severe and the most difficult to treat. In 2016, the American Headache Society (AHS) released new evidence-based guidelines for the treatment of CH.1 Treatments ...

 


Coverage Gaps Leave Cluster Headache Undertreated: Part I - Neurology Advisor



Neurology Advisor
 
Coverage Gaps Leave Cluster Headache Undertreated: Part I 
Neurology Advisor
In a blistering condemnation of the fallout from a regulatory decision made in 2011,2 the authors wrote that "the US Centers for Medicaid and Medicare Services [CMS] has made the indefensible decision to not cover oxygen for cluster headache for ...

 


Cluster headaches: what are the causes, symptoms and treatments - Cosmopolitan.com



Cosmopolitan.com
 


Antares Pharma Receives Complete Response Letter From the FDA ... - GlobeNewswire (press release)



Antares Pharma Receives Complete Response Letter From the FDA ... 
GlobeNewswire (press release)
EWING, N.J., Oct. 20, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) announced that today it has received a Complete Response Letter ...

and more » 


6 conditions you may not realize physical therapists treat - WOTV4women.com



WOTV4women.com
 
6 conditions you may not realize physical therapists treat 
WOTV4women.com
Headaches: There are many different type of headaches including tension headaches, migraines and cluster headaches to name a few. Often times, headaches can become a very frequent occurrence that affects a persons ability to function on a daily basis.

 


What your headache is trying to tell you | Now To Love - Now To Love



Now To Love
 
What your headache is trying to tell you | Now To Love 
Now To Love
Ever find yourself mindlessly rubbing your temples in a bid to ease the pain of one almighty, brain-pounding headache? Well, you're not alone; the World Health ...
New survey reveals concerns about impact of migraine on work ... EurekAlert (press release)

all 3 news articles » 


Occipital Nerve Stimulation Suitable for Intractable Primary Headaches - Clinical Pain Advisor



Clinical Pain Advisor
 
Occipital Nerve Stimulation Suitable for Intractable Primary Headaches 
Clinical Pain Advisor
... stimulation to determine response predictors in migraine and/or headache attacks. A total of 35 patients had chronic migraine, 20 had short-lasting unilateral neuralgiform headache attacks, 33 had chronic cluster headache, and 12 had hemicrania ...

 


Antares Pharma Provides XYOSTED? Regulatory Update - GlobeNewswire (press release)



Finance News Daily
 
Antares Pharma Provides XYOSTED? Regulatory Update 
GlobeNewswire (press release)
The Company's product Sumatriptan Injection USP, is approved in the U.S. for the acute treatment of migraine and cluster headache and is distributed by Teva Pharmaceutical Industries, Ltd. (Teva). Antares Pharma is also developing XYOSTED? for ...
Antares Pharma, Inc. - ATRS - Stock Price Today - Zacks Zacks Investment Research

all 136 news articles »